We also observed that the pathways affecting CD73 are not identical in murine- and human-lineage pancreatic cancer cells, so it would be prudent to continue crossover or combinatorial screening between different cell lines and different species in future experiments to find the critical targets for regulating CD73. The gene discussed is NT5E; the disease is familial pancreatic carcinoma.